English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/75349
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

The promoter activity of human Mfn2 depends on Sp1 in vascular smooth muscle cells

AuthorsVila-Caballer, Marian; González-Navarro, Herminia ; Portugal, José ; Andrés, Vicente; Palacín, Manuel; Zorzano, Antonio
KeywordsVascular smooth muscle cells
Mitochondrial dynamics
Mitofusin
Sp1 transcription factor
Vascular proliferative disorders
Issue Date17-Jan-2012
PublisherOxford University Press
European Society of Cardiology
CitationCardiovascular Research 94(1): 38-47 (2012)
Abstract[Aims]: Mitofusin-2 (Mfn2) expression is dysregulated in vascular proliferative disorders and its overexpression attenuates the proliferation of vascular smooth muscle cells (VSMCs) and neointimal lesion development after balloon angioplasty. We sought to gain insight into the mechanisms that control Mfn2 expression in VSMCs. [Methods and results]: We cloned and characterized 2 kb of the 5'-flanking region of the human Mfn2 gene. Its TATA-less promoter contains a CpG island. In keeping with this, 5'-rapid amplification of cDNA ends revealed six transcriptional start sites (TSSs), of which TSS2 and TSS5 were the most frequently used. The strong CpG island was found to be non-methylated under conditions characterized by large differences in Mfn2 gene expression. The proximal Mfn2 promoter contains six putative Sp1 motifs. Sp1 binds to the Mfn2 promoter and its overexpression activates the Mfn2 promoter in VSMCs. Chemical inhibition of Sp1 reduced Mfn2 expression, and Sp1 silencing reduced transcriptional activity of the Mfn2 promoter. In keeping with this view, Sp1 and Mfn2 mRNA levels were down-regulated in the aorta early after an atherogenic diet in apolipoprotein E-knockout mice or in VSMCs cultured in the presence of low serum. [Conclusion]: Sp1 is a key factor in maintaining basal Mfn2 transcription in VSMCs. Given the anti-proliferative actions of Mfn2, Sp1-induced Mfn2 transcription may represent a mechanism for prevention of VSMC proliferation and neointimal lesion and development.
Description10 páginas, 6 figuras.-- et al.
Publisher version (URL)http://dx.doi.org/10.1093/cvr/cvs006
URIhttp://hdl.handle.net/10261/75349
DOI10.1093/cvr/cvs006
ISSN0008-6363
E-ISSN1755-3245
Appears in Collections:(IBV) Artículos
(IBMB) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.